Stokes Family Office’s iShares iBonds Dec 2034 Term Corporate ETF IBDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$821K Buy
31,515
+4,515
+17% +$118K 0.1% 143
2026
Q1
$704K Hold
27,000
0.07% 160
2025
Q4
$712K Hold
27,000
0.07% 164
2025
Q3
$715K Hold
27,000
0.07% 151
2025
Q2
$706K Hold
27,000
0.07% 136
2025
Q1
$696K Buy
27,000
+12,000
+80% +$307K 0.08% 136
2024
Q4
$382K Buy
+15,000
New +$389K 0.04% 183

Other funds holding IBDZ

Stokes Family Office's IBDZ Position: Q2 2026 in Review

Stokes Family Office increased its iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) stake by 17% in Q2 2026, buying an estimated $118K and bringing the position to 31,515 shares worth $821K. The position accounts for 0.1% of the portfolio, ranked #143.

Stokes Family Office first reported a position in IBDZ in Q4 2024 and has held it in 7 quarters since. 128 funds tracked by Wall St. Rank hold IBDZ as of Q2 2026.

  • Stokes Family Office held 31,515 shares of iShares iBonds Dec 2034 Term Corporate ETF worth $821K as of Q2 2026.
  • Stokes Family Office bought 4,515 iShares iBonds Dec 2034 Term Corporate ETF shares in Q2 2026, an estimated $118K.
  • iShares iBonds Dec 2034 Term Corporate ETF made up 0.1% of Stokes Family Office's portfolio in Q2 2026, its #143 holding.
  • Stokes Family Office first reported a position in iShares iBonds Dec 2034 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 128 funds tracked by Wall St. Rank held iShares iBonds Dec 2034 Term Corporate ETF as of Q2 2026.

Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.